Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 8Cholangiocarcinoma 4Biliary Tract Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Gallbladder Neoplasms 2Colonic Neoplasms 2Adenocarcinoma Of Esophagus 2Rectal Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Disease Progression 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma, Basal Cell 1Bile Duct Neoplasms 1

Interventions

Oxaliplatin 10Fluorouracil 9Capecitabine 8Leucovorin 6Nivolumab 4Cetuximab 4Specimen Handling 3Radiotherapy 3Magnetic Resonance Spectroscopy 3pembrolizumab 2fludarabine 2dostarlimab 2aldesleukin 2Trastuzumab 2Tomography, X-Ray Computed 2Surveys and Questionnaires 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2Radiation 2Pemetrexed 2Magnetic Resonance Imaging 2Gemcitabine 2Electrocardiography 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2Bevacizumab 2ulixertinib 1tucatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Folfox protocol × 30 days × Clear all
NCT03548961 2026-05-22

Organ Preservation in Early Rectal Cancer Patients

Fox Chase Cancer Center

Phase 2 Active not recruiting
19 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡